Viewing nowCombinationZadiglimmet Tablet 5/500 mg (Empagliflozin 2L-Proline, Metformin)
Empagliflozin 2L-Proline 7.56mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.

MFDS item code 202503006 · Approved 2025.11.19
Improvement of glycemic control in adults with type 2 diabetes
This medication is used in combination with empagliflozin and metformin to improve blood sugar control in patients with type 2 diabetes. It is particularly effective when used alongside dietary and exercise interventions to manage blood sugar effectively. Additionally, in adults with type 2 diabetes who do not achieve sufficient blood sugar control and have cardiovascular disease, caution should be taken regarding the risk of cardiovascular events when using this medication, referring to specialized clinical trial information. Overall, this medication helps improve blood sugar control in patients with type 2 diabetes.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient's current metformin dose. If the patient tolerates empagliflozin 10 mg (total daily dose) well but requires additional glycemic control, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in such cases. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately. In patients aged 75 years and older, consider renal function and the risk of volume depletion.
This medication is an agent that helps lower blood sugar levels and is primarily used in diabetes treatment. When taking this medication, there is a risk of serious side effects such as lactic acidosis. Lactic acidosis is a dangerous condition that occurs when there is excessive accumulation of lactic acid in the body, with symptoms including fatigue, muscle pain, difficulty breathing, and abdominal pain. Furthermore, taking this medication in combination with other diabetes medications like insulin or sulfonylureas can increase the risk of hypoglycemia, so careful monitoring of blood sugar changes is essential. Patients with decreased kidney function or conditions such as dehydration, severe infections, or rapidly worsening heart function may be at risk when taking this medication and should avoid its use. It is particularly advised that individuals undergoing surgery, those undergoing tests involving iodinated contrast agents, and women who are pregnant or breastfeeding should refrain from taking this medication. This medication may affect kidney function, making it necessary to have regular kidney function tests and adjust dosage or discontinue use depending on the condition. Additionally, this medication can increase the risk of urinary or genital infections, so patients should consult a healthcare professional immediately if infection symptoms occur. Vitamin B12 levels may decrease, so it is recommended to conduct blood tests to check vitamin B12 status during long-term use. Elderly patients or those at risk of fluid loss should be cautious of dehydration and hypotension and ensure adequate hydration and monitoring of their conditions. It is advisable to avoid alcohol while taking this medication, and to inform healthcare professionals immediately if symptoms such as sudden weight loss, severe fatigue, or difficulty breathing occur. Lastly, this medication is not recommended for children and caution may be necessary when driving or operating machinery.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container, protected from air and moisture, and kept at room temperature between 1 and 30 degrees Celsius. This way, the efficacy of the medication can be maintained and it can be used safely.
Orange-yellow, oval-shaped film-coated tablets, biconvex on both sides
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 2L-Proline 7.56mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.9mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.